cembra-2-7-11-triene-4-6-diol has been researched along with Substance-Withdrawal-Syndrome* in 1 studies
1 other study(ies) available for cembra-2-7-11-triene-4-6-diol and Substance-Withdrawal-Syndrome
Article | Year |
---|---|
A cembranoid from tobacco prevents the expression of nicotine-induced withdrawal behavior in planarian worms.
Using an adaptation of published behavioral protocols, we determined that acute exposure to the cholinergic compounds nicotine and carbamylcholine decreased planarian motility in a concentration-dependent manner. A tobacco cembranoid (1S,2E,4R,6R,7E,11E)-cembra-2,7,11-triene-4,6-diol (4R-cembranoid), also decreased planarian motility. Experiments in the presence of 1 microM 4R-cembranoid did increase the IC50 for nicotine- but not carbamylcholine-induced decrease in planarian motility. When planarians were exposed for 24 h to either nicotine or carbamylcholine at concentrations near their respective IC50 values and then transferred to plain media, nicotine-exposed, but not carbamylcholine- or cembranoid-exposed worms displayed withdrawal-like distress behaviors. In experiments where planarians were pre-exposed to 100 microM nicotine for 24 h in the presence of 1 microM 4R-cembranoid, the withdrawal-like effects were significantly reduced. These results indicate that the 4R-cembranoid might have valuable applications for tobacco abuse research. This experimental approach using planarians is useful for the initial screening of compounds relevant to drug abuse and dependence. Topics: Animals; Behavior, Animal; Carbachol; Diterpenes; Motor Activity; Nicotiana; Nicotine; Planarians; Substance Withdrawal Syndrome | 2009 |